NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read Now

GLOBAL MARKETS-Asian shares near record highs as U.S. stimulus plans offset virus woes

Published 25/01/2021, 05:33 pm
© Reuters.
EUR/USD
-
GBP/USD
-
USD/JPY
-
UK100
-
XAU/USD
-
US500
-
DJI
-
AXJO
-
DE40
-
JP225
-
HK50
-
AZN
-
PFE
-
DE30
-
DX
-
GC
-
LCO
-
ESU24
-
CL
-
EU50
-
IXIC
-
MIAPJ0000PUS
-
CSI300
-

* Asian stock markets : https://tmsnrt.rs/2zpUAr4

By Swati Pandey

SYDNEY, Jan 25 (Reuters) - Asian shares climbed to near all-time highs on Monday as concerns over rising COVID-19 cases and delays in vaccine supplies were eclipsed by optimism of a $1.9 trillion fiscal stimulus plan to help revive the U.S. economy.

Sentiment in the region was also boosted by a report that China had surpassed the United States to be the largest recipient of foreign direct investment in 2020 with $163 billion in inflows. markets also pointed to firmer starts elsewhere. E-mini futures for the S&P 500 ESc1 rose 0.37%, futures for eurostoxx 50 STXEc1 as well as London's FTSE were up 0.3% each while those for Germany's DAX FDXc1 added 0.4%.

"The FDI story has definitely lifted China and its near neighbours today, blowing an economic recovery tailwind into geographically adjacent markets," said OANDA's Singapore-based market analyst Jeffery Halley.

"Looking ahead, equities will find more meaningful reactions from the progress or not of the Biden stimulus package, and the level of dovishness displayed by the Federal Reserve at their FOMC meeting this week."

Global equity markets have scaled record highs in recent days on bets COVID-19 vaccines will start to reduce the infection rates worldwide and on a stronger U.S. economic recovery under President Joe Biden.

Still, investors are also wary about towering valuations amid questions over the efficiency of the vaccines in curbing the pandemic and as U.S.lawmakers continue to debate a coronavirus aid package. broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS rose to 726.46, within kissing distance of last week's record high of 727.31.

The benchmark is up nearly 9% so far in January, on track for its fourth straight monthly rise.

Japan's Nikkei .N225 rebounded from falls in early trading to be up 0.7%.

Australian shares .AXJO added 0.4% after the country's drug regulator approved the Pfizer/BioNTech COVID-19 vaccine with a phased rollout likely late next month. shares rose, with the blue-chip CSI300 index .CSI300 up 1.1%. Hong Kong's Hang Seng index .HSI leapt nearly 2% led by technology stocks.

All eyes are on Washington DC as U.S. lawmakers agreed that getting the COVID-19 vaccine to Americans should be a priority even as they lock horns over the size of the U.S. pandemic relief package. markets have been eyeing a massive package though disagreements have meant months of indecision in a country suffering more than 175,000 COVID-19 cases a day with millions out of work.

Global COVID-19 cases are inching towards 100 million with more than 2 million dead. Kong locked down an area of the Kowloon peninsula on Saturday, the first such measure the city has taken since the pandemic began.

Reports the new UK COVID variant was not only highly infectious but perhaps more deadly than the original strain also added to worries. the European Union, political leaders expressed widespread dismay over a hold-up by AstraZeneca AZN.L and Pfizer Inc (NYSE:PFE) PFE.N in delivering promised doses, with Italy's prime minister lashing out at the vaccine suppliers, saying delays amounted to a serious breach of contractual obligations. Friday, the Dow .DJI fell 0.57%, the S&P 500 .SPX lost 0.30% and the Nasdaq .IXIC added 0.09%. The three main U.S. indexes closed higher for the week, with the Nasdaq up over 4%.

Jefferies analysts said U.S. stock markets looked overvalued though they still remained bullish.

"For the stock market to have a real nasty unwind, rather than just a bull market correction, there needs to be a catalyst," analyst Christopher Wood said.

"That means either an economic downturn or a material tightening in Fed policy," Wood said, adding neither was likely to occur in a hurry.

In currencies, major pairs were trapped in a tight range as markets awaited the Fed's Wednesday meeting.

The dollar index =USD eased to 90.073, with the euro EUR= at $1.2181, while sterling GBP= was last a tad firmer at $1.3721.

The Japanese yen JPY= was a shade weaker at 103.69 per dollar.

In commodities, Brent LCOc1 gave up early losses to be last flat at $55.41 a barrel and U.S. crude CLc1 rose 3 cents to $52.30.

Gold was flat at $1,852.9 an ounce. XAU=

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Asia stock markets

https://tmsnrt.rs/2zpUAr4 Asia-Pacific valuations

https://tmsnrt.rs/2Dr2BQA

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^> (Editing by Shri Navaratnam and Jacqueline Wong)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.